Process for the preparation of (3E, 7E)-homofarnesol

US9758500B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9758500-B2
Application numberUS-201615291129-A
CountryUS
Kind codeB2
Filing dateOct 12, 2016
Priority dateApr 16, 2012
Publication dateSep 12, 2017
Grant dateSep 12, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to new types of processes for the improved preparation of homofarnesol, in particular of (3E,7E)-homofarnesol and homofarnesol preparations with an increased content of (3E,7E)-homofarnesol (also referred to as all E-homofarnesol).

First claim

Opening claim text (preview).

The invention claimed is: 1. A process for preparing compounds of formula I in which R 1 is a straight-chain or branched, optionally mono- or polyunsaturated hydrocarbyl radical, and R 2 is H or C 1 -C 6 -alkyl, where a) a carbonyl compound of formula II in which R 1 and R 2 have the meanings above, is reacted by means of Wittig olefination to give a cyclopropane of formula (III) b) the cyclopropane of the formula III is reacted, with ring opening, to give a compound of formula IV in which X is halogen or O—R′, in which R′ is H, acyl, Tf-acetyl or SO 2 —R″, and R″ is alkyl or aryl; and c) the compound of the formula IV is converted to the formula I compound. 2. The process according to claim 1 , where a cyclopropylphosphonium salt is used for the Wittig olefination according to stage a). 3. The process according to claim 2 , in which the cyclopropylphosphonium salt is a triphenylphosphonium compound of formula V in which Z − is the anion of a strong acid. 4. The process according to claim 3 , where the compound of the formula V is prepared by reacting a) bromobutyrolactone with triphenylphosphine and thermally decarboxylating the reaction product, or by reacting b) 1,3-dibromopropane with triphenylphosphine and cyclizing the reaction product. 5. The process according to claim 1 , wherein the ring-opening in stage b) takes place in the presence of a Lewis acid or Brönstedt acid/protonic acid, and a nucleophile. 6. The process according to claim 5 , where the ring opening of step b) provides E-selectively with respect to R 1 , where E:Z is greater than 1.5. 7. The process according to claim 1 , wherein for stage c), X is OR′, and carrying out an ester cleavage, or X is halogen, and converting the halide to a corresponding ester, and then cleaving the corresponding ester. 8. The process according to claim 1 , wherein the formula I compound is (3E,7E)-homofarnesol of formula Ia 9. The process according to claim 8 , where, in stage a), E-geranyl acetone of formula IIa is reacted with cyclopropylphosphonium halogenide to provide a compound of formula IIIa 10. A process for preparing enantiomerically pure ambrox or a stereoisomer mixture of ambrox, where (3E,7E)-homofarnesol is prepared by a process according to claim 1 and the (3E,7E)-homofarnesol is cyclized to give enantiomerically pure (−)-ambrox, 3aR,5aS,9aS,9bR)-3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan, or a stereoisomer mixture of 3aR,5aS,9aS,9bR)-3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan. 11. The process according to claim 6 , where the E-selectivity with respect to R 1 is a molar excess of E:Z in a range from 2:1 to 50:1. 12. The process according to claim 1 , where R 1 is a C 1 -C 20 hydrocarbyl radical with one or more conjugated or non-conjugated double bond. 13. The process according to claim 12 , where R 2 is a methyl or ethyl. 14. The process according to claim 1 , where R 2 is a methyl or ethyl. 15. The process according to claim 14 , where R 1 is a C 1 -C 20 hydrocarbyl radical with one or more non-conjugated radicals of formula where n is 2, 3, or 4.

Assignees

Inventors

Classifications

  • with a three-membered ring · CPC title

  • of halides · CPC title

  • C07D307/92Primary

    Naphthofurans; Hydrogenated naphthofurans · CPC title

  • by elimination of halogen, e.g. by hydrogenolysis, splitting-off (C07C29/124 takes precedence) · CPC title

  • with a three-membered ring · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9758500B2 cover?
The present invention relates to new types of processes for the improved preparation of homofarnesol, in particular of (3E,7E)-homofarnesol and homofarnesol preparations with an increased content of (3E,7E)-homofarnesol (also referred to as all E-homofarnesol).
Who is the assignee on this patent?
Basf Se
What technology area does this patent fall under?
Primary CPC classification C07D307/92. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).